Gressami 100mg Tablet contains Amisulpride, an atypical antipsychotic agent primarily used in the treatment of schizophrenia and other psychotic disorders. Amisulpride exerts its therapeutic effects by selectively antagonizing dopamine D2 and D3 receptors in the brain, thereby modulating dopaminergic neurotransmission implicated in psychosis. This medication is indicated for the management of both positive symptoms, such as hallucinations and delusions, and negative symptoms, including social withdrawal and apathy. Gressami 100mg is typically administered orally, with dosage tailored according to the severity of symptoms and patient response, under medical supervision. It is essential to monitor patients for potential side effects, which may include extrapyramidal symptoms, hyperprolactinemia, weight gain, and metabolic changes. Caution is advised in patients with a history of cardiac disorders, as amisulpride may prolong the QT interval. Regular assessment of renal and hepatic function is recommended during prolonged therapy. Gressami should be used with care in elderly patients and those with concomitant medical conditions. Abrupt discontinuation should be avoided to prevent withdrawal symptoms or relapse. This medication should be prescribed and dispensed by qualified healthcare professionals, with adherence to recommended guidelines to ensure safety and efficacy.